ArticleSpringerPlus2016

Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience.

Amr Shaaban HanafyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.